ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Highly-sensitized"

  • 2020 American Transplant Congress

    Waiting List and Transplant Outcomes of Highly Sensitized Kidney Patients

    R. Schmitz, O. K. Jawitz, S. J. Knechtle, A. M. Jackson

    Department of Surgery, Duke University Medical Center, Durham, NC

    *Purpose: Sensitized kidney transplant candidates represent a growing population on the waiting list. Transplantation of patients with high calculated panel reactive antibody (CPRA) can be…
  • 2020 American Transplant Congress

    In-Vivo Application of Ides (Imlifidase) in Nonhuman Primates Results in Xenoreactive Desensitization: A Novel Anti-Humoral Therapy

    B. P. Lovasik1, A. J. Matar1, D. A. Faber1, D. V. Mathews1, C. Breeden1, S. C. Kim1, A. J. Tector2, A. Robertson3, C. Kjellman3, A. B. Adams1

    1Emory University School of Medicine, Atlanta, GA, 2University of Miami, Miami, FL, 3HANSA Biopharma, Lund, Sweden

    *Purpose: Antibody-mediated rejection is a formidable barrier to xenograft survival. A novel anti-humoral IdeS therapy, which cleaves serum IgG, represents a promising therapy to reduce…
  • 2020 American Transplant Congress

    The Clinical Relevance of cPRA in 0-ABDRDQ Mismatched Kidney Transplants

    J. H. Lan1, D. Chang1, M. Kadatz1, J. Gill1, H. M. Gebel2, J. S. Gill1

    1Medicine, Division of Nephrology, University of British Columbia, Vancouver, BC, Canada, 2Pathology, Emory University, Atlanta, GA

    *Purpose: The clinical relevance of immune sensitization as measured by cPRA in kidney transplantation remains uncertain.*Methods: We identified 4,057 adult, first, kidney only transplant recipients…
  • 2020 American Transplant Congress

    A Single Centre Report of Renal Transplantation Against a Positive Crossmatch Due to HLA-DP Donor Specific Antibodies without Prior Antibody Removal

    Y. Marie1, T. Key2, A. Halawa1

    1Renal Transplantation, Sheffield Kidney Institute, Sheffield, United Kingdom, 22.Department of Histocompatibility and Immunogenetics, Sheffield, United Kingdom

    *Purpose: In renal transplantation, the clinical effects of donor specific antibodies (DSA) against HLA-DP are unclear. We report successful kidney transplants in three highly sensitised…
  • 2020 American Transplant Congress

    Accommodating Increasing Volumes without Knocking Down Walls: Update on an Infusion Center’s Growth

    J. C. Estrada

    Comprehensive Transplant Center, Cedars Sinai Medical Center, Los Angeles, CA

    *Purpose: An increase in transplants performed at the medical center in comparison to the limited availability of outpatient infusion chairs and home infusion companies compelled…
  • 2020 American Transplant Congress

    Risk Factors for Antibody-Mediated Rejection after Adult Liver Transplantation with Preformed Donor-Specific Antibodies: A Single Center Experience

    T. Tajima, K. Hata, J. Kusakabe, H. Miyauchi, T. Anazawa, T. Ito, S. Uemoto

    Div. of HBP Surgery and Transplantation, Dept. of Surgery, Kyoto University, Kyoto, Japan

    *Purpose: In general, preformed donor-specific antibodies (pDSAs) can lead to an increased risk of antibody-mediated rejection (AMR); however, their prevalence, risk factors, and the efficacy…
  • 2020 American Transplant Congress

    Desensitization Combining Costimulation Blockade with Proteasome Inhibition in Highly Sensitized Transplant Candidates

    S. Restaino1, D. Jennings2, G. Serban3, E. Vasilescu3, G. Sayer1, N. Uriel1, K. Takeda4, Y. Naka4, M. Farr1, M. V. Habal1

    1Cardiology, Columbia University Irving Medical Center, New York, NY, 2School of Nursing, Columbia University Irving Medical Center, New York, NY, 3Pathology&Cell Biology, Columbia University Irving Medical Center, New York, NY, 4Cardiothoracic Surgery, Columbia University Irving Medical Center, New York, NY

    *Purpose: Antibodies to human leukocyte antigens (HLA) pose a significant barrier to transplantation. Strategies to reduce allosensitization have modest efficacy and may result in antibody…
  • 2020 American Transplant Congress

    Kidneys from Pediatric Donors Are Preferentially Allocated to Adult Highly Sensitized and Not to Pediatrics Under the New Kidney Allocation System (KAS)

    D. Puliyanda1, H. Pizzo1, J. Garrison1, S. Williamson2, I. Kim2, E. Huang2

    1Pediatric Nephrology, Cedars-Sinai Medical Center, Los Angeles, CA, 2Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA

    *Purpose: In 12/2014, the new Kidney Allocation System (KAS) assigned allocation priority to highly sensitized (HS) recipients while maintaining access to donors for pediatric patients…
  • 2020 American Transplant Congress

    Blocking Complement Component C3 in a Sensitized Nonhuman Primate Model of Kidney Allotransplantation

    R. Schmitz1, P. M. Schroder1, Z. W. Fitch1, A. Y. Choi1, M. Manook1, J. Yoon1, A. Farris2, E. S. Reis3, J. D. Lambris3, J. Kwun1, S. J. Knechtle1

    1Department of Surgery, Duke University Medical Center, Durham, NC, 2Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, 3Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA

    *Purpose: Sensitized transplant recipients represent a challenge due to the presence of donor-specific antibodies (DSA), which increase the risk of antibody-mediated rejection. Complement inhibition has…
  • 2020 American Transplant Congress

    Outcomes of HLAi Transplant in CPRA 98-100 after Desensitization: Single Center Experience

    A. Vo1, E. Huang1, M. Haas2, S. Williamson1, C. Meyers1, A. Peng1, R. Najjar1, S. Sethi1, N. Ammerman1, K. Lim1, M. Gillespie1, S. C. Jordan1

    1Cedars Sinai Medical Ctr, Los Angeles, CA, 2Pathology, Cedars Sinai Medical Ctr, Los Angeles, CA

    *Purpose: The new KAS implementation aimed at increasing equity in organ allocation for broadly sensitized (HS) patients. However, recent data shows that for the most…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 15
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences